Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Clinical Trials

Discovery & Development Clinical Trials

Malaysia in the Middle: Tackling Hep C in an Unfair World

| Angus Stewart

How the Drugs for Neglected Diseases Initiative and the Malaysian government partnered to tackle hep C with an affordable, effective cure.

Manufacture Drug Discovery

Bringing Certainty to CAR T-Cell Discovery

| Jim Ross

How can we maximize the potential and production of potentially life-saving therapies?

Discovery & Development Clinical Trials

The Global Stage

| Claudia Berron

When it comes to conducting clinical trials in emerging geographies, there are four key challenges to consider.

Business & Regulation Standards & Regulation

The Winding Road to the Frontline for Advanced Therapies

| Angi Robinson

How can we ease the process of taking ATMPs to clinical trials? Two experts lay out the key considerations.

Discovery & Development Clinical Trials

Hope in the Fight Against Malaria

| Angus Stewart

Can a new malaria vaccine hold the key to reliable, durable protection?

Business & Regulation Clinical Trials

Inclusive Drug Development

| Ann Taylor

The lack of female representation in clinical trials impairs the very foundation that the development of safe and effective medicines is built upon.

Manufacture Packaging

The Value of a Pack

| Adrian Collins

As trials change and adapt, so too must clinical packaging.

Business & Regulation Business Practice

The Human Yin to the Clinical Yang

| Maryam Mahdi

How can advocacy groups help improve the clinical trials landscape?

Business & Regulation COVID-19

Catching Up With... Rick Bright

| Stephanie Sutton

We catch up with our Power Lister Rick Bright, to get his thoughts on the future of biopharma.

Discovery & Development Clinical Trials

Protecting the Vulnerable

| Maryam Mahdi

A trial sets out to explore the effects of various COVID-19 vaccines on vulnerable patients.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register